Skip to main content
Oculis Holding AG logo

Oculis Holding AG — Investor Relations & Filings

Ticker · OCS ISIN · CH1242303498 LEI · 5067005370C2KK324336 IC Manufacturing
Filings indexed 321 across all filing types
Latest filing 2025-05-09 Regulatory Filings
Country CH Switzerland
Listing IC OCS

About Oculis Holding AG

https://www.oculis.com/

Oculis Holding AG is a global, clinical-stage biopharmaceutical company focused on developing innovative therapies for ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs. The company's pipeline aims to transform current treatment paradigms. Key candidates include OCS-01, a topical eye drop using the proprietary OPTIREACH® technology, investigated as a potential first non-invasive treatment for Diabetic Macular Edema (DME). Another lead asset is Privosegtor, a novel peptoid small molecule being developed as a neuroprotective therapy for optic neuropathies such as Acute Optic Neuritis. The pipeline also features Licaminlimab, an anti-TNFα eye drop candidate for treating Dry Eye Disease.

Recent filings

Filing Released Lang Actions
6-K
Regulatory Filings
2025-05-09 English
Oculis birtir boð á aðalfund
AGM Information Classification · 98% confidence The document text is a press release titled 'Oculis birtir boð á aðalfund' (Oculis publishes notice of Annual General Meeting). It explicitly states the date, time, and location for the 2025 Annual General Meeting (AGM) and mentions that materials regarding the AGM proposals are available. This directly corresponds to the definition of AGM Information (AGM-R). Although it is a short announcement, the core content is the notice/invitation to the AGM itself, making AGM-R a more specific fit than a general Report Publication Announcement (RPA) or Regulatory Filing (RNS).
2025-05-09 Icelandic
Oculis Publishes Invitation to the Annual General Meeting
AGM Information Classification · 99% confidence The document explicitly states, 'Oculis Publishes Invitation to the Annual General Meeting' and provides details about the upcoming 2025 Annual General Meeting (AGM), including the date, time, and location. This content directly relates to the materials shared for an AGM. Although it mentions meeting materials can be accessed elsewhere, the primary purpose of this specific announcement is to publish the invitation and related information for the AGM. This aligns perfectly with the 'AGM Information' category (AGM-R).
2025-05-09 English
Oculis Publishes Invitation to the ..
AGM Information Classification · 98% confidence The document text is a press release titled "Oculis Holding AG - Boðun hluthafafundar" (Oculis Holding AG - Notice of General Meeting) and explicitly states that Oculis published the notice for its 2025 Annual General Meeting (AGM) scheduled for June 4, 2025. It also mentions an informational call for shareholders leading up to the AGM. This content directly relates to the scheduling and notification of the Annual General Meeting. Therefore, the appropriate classification is AGM Information (AGM-R). The document length (4027 chars) is substantial enough that it is the primary announcement/material, not just a brief RPA.
2025-05-09 Icelandic
Oculis Publishes Invitation to the ..
AGM Information Classification · 98% confidence The document explicitly states 'Oculis Holding AG - Notice to general meeting' and 'Oculis Publishes Invitation to the Annual General Meeting'. It details the date, time, and location for the '2025 Annual General Meeting'. This content directly relates to the materials and notices associated with the Annual General Meeting. Although it is an announcement/invitation, the specific category for AGM materials is 'AGM-R' (AGM Information), which covers presentations and materials shared during the AGM. Given the focus on the meeting invitation and materials, AGM-R is the most precise fit over a general RPA or RNS.
2025-05-09 English
6-K
Regulatory Filings
2025-05-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.